(2E)-3-{3-[(5-ETHYL-3-IODO-6-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-4-YL)OXY]PHENYL}ACRYLONITRILE

Star0

DB07035ExperimentalSmall molecule

(2E)-3-{3-[(5-ETHYL-3-IODO-6-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-4-YL)OXY]PHENYL}ACRYLONITRILE: Overview.

Formula / weight: C₁₇H₁₅IN₂O₂ · 406.2177 g/mol (avg)

Resolves to

Compound

PubChem5459348

Structure

InChIKeyXMFUXIRAVPMVRS-FNORWQNLSA-NSMILESCCC1=C(C)NC(=O)C(I)=C1OC1=CC=CC(\C=C\C#N)=C1

Targets

P03366gag-pol

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with (2E)-3-{3-[(5-ETHYL-3-IODO-6-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-4-YL)OXY]PHENYL}ACRYLONITRILE, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account